ערך בספרים למניה: Haoxi Health Technology (HAO)

Haoxi Health Technology's business is subject to the strong cyclicality of the Chinese advertising market and is sensitive to macro shocks. The history of book value per share visualizes capital dynamics, where 3191.97 expresses the latest level of the metric. The company is currently undergoing a stabilization phase, implementing short-form videos to protect margins. The agency's revenues are based on the promotion of medical centers and social media management.

The stable income of Haoxi Health Technology (HAO), underpinned by long-term B2B contracts with Chinese clinics, creates a reliable foundation for net asset growth. By analyzing the balance sheet valuation on a per-share basis, an investor can identify the residual business value net of liabilities, which allows for the determination of the stock's intrinsic value and an assessment of the extent of its undervaluation relative to market quotes.